Digital Divide May Contribute to Telehealth Disparities
Access to internet-connected devices with cameras and skill in using digital platforms present barriers to a large portion of the population.
Home
Risk Stratification in Cystic Fibrosis Patients Listed for Lung Transplantation
A newly developed cystic fibrosis frailty index calculates the risk for poor outcomes both in patients post lung transplant and among those awaiting transplant.
Time to Advanced Airway Management in Pediatric Out-of-Hospital Cardiac Arrest
How is the survival of children experiencing out-of-hospital cardiac arrest affected by the timing of advanced airway management?
Immunocompromised Patients With COVID-19 and Risk for ICU Admission, Mortality
Researchers sought to evaluate whether immunocompromised individuals infected with COVID-19 are at a higher risk for ICU admission and death compared with nonimmunocompromised individuals.
Combo Could Be New Standard After EGFR TKI Failure in NSCLC
Sintilimab, IBI305, and chemotherapy could be a new standard of care for patients with EGFR-mutant NSCLC that progressed on an EGFR TKI.
Poll: Inflation Has Many Americans Cutting Back on Health Care
Inflation is putting Americans’ health at risk, with nearly two in five struggling to pay for the care they need, according to a new West Health-Gallup poll.
Pulmonary Artery Diameter as a Prognostic Marker for COVID-19 Severity
Are COVID-19 outcomes associated with a patient’s baseline pulmonary artery diameter measurement obtained from non-contrast non-gated computed tomography?
Cost-Effectiveness of Anti-Immunoglobulin E Biologic Therapy for Severe Asthma
A Mexican real-world study assessed the treatment costs of anti-IgE biological therapy for severe asthma in patients with controlled and uncontrolled asthma.
Erythema Nodosum Linked to Better Prognosis in Patients With Sarcoidosis
The clinical characteristics and treatment-related features in patients with sarcoidosis are compared based on if EN was a presenting symptom at the time of diagnosis.
Ensifentrine Improves Lung Function, Reduces COPD Exacerbations in Late Stage Trial
Ensifentrine (RPL554) is a first-in-class, dual phosphodiesterase (PDE) 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory actions.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in COPD
Loading... 
Loading...